文献速递临床试验与 GCP

机器人对比常规腹腔镜胆囊切除术治疗良性胆囊疾病:随机对照非劣效性试验

Surgical Techniques: Robotic versus conventional Laparoscopic cholecystectomy IN benign Gallbladder disease: a randomized controlled, open, parallel, non-inferiority, single-center trial (STaRLING trial).
PubMed 文献 · Trials · 2026-02-24

本研究为单中心、随机对照、开放、平行、非劣效性试验,计划纳入276例有胆囊切除术指征的良性胆囊疾病成人患者,随机接受机器人胆囊切除术(RC)或腹腔镜胆囊切除术(LC)。主要终点为术后30天内并发症的发生率和严重程度,旨在评估RC相对于LC的非劣效性,为机器人手术的临床应用提供证据。

要点

  • 首个比较机器人胆囊切除术与腹腔镜胆囊切除术的随机对照试验。
  • 主要终点为术后30天内并发症发生率和严重程度。
  • 计划样本量276例,随访至术后30天。

核心结论

  • 该试验旨在评估机器人胆囊切除术相对于腹腔镜胆囊切除术的非劣效性,目前尚无结果。

研究设计与样本

  • 前瞻性单中心随机对照开放平行非劣效性试验,计划纳入276例良性胆囊疾病成人患者,随机分配至RC或LC组。

关键数值与推荐

  • 主要终点为术后30天内并发症的发生率和严重程度。
  • 次要终点包括围手术期结局、总医疗资源利用、患者报告结局测量的健康相关生活质量(HR-QoL)及成本效果。
  • 随访评估在术后7天和30天进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic surgery is increasingly being adopted for gallbladder removal, despite the absence of randomized trials comparing its safety and patient outcomes to the current gold standard, laparoscopic cholecystectomy (LC). Existing literature reviews have found several case series showing no significant differences in postoperative complications or recovery between robotic cholecystectomy (RC) and LC. This trial aims to evaluate whether RC is non-inferior to conventional LC. METHODS: This is a prospective single-center, randomized controlled, parallel, non-inferiority trial. All adult patients with benign gallbladder disease with an indication for cholecystectomy will be assessed for eligibility and included after obtaining informed consent. A total of 276 patients will be randomized to undergo either RC or LC. The primary endpoint will be the incidence and severity of postoperative complications within 30 days after surgery. Secondary endpoints include perioperative outcomes, total health care utilization, health-related quality of life (HR-QoL) as assessed by patient-reported outcome measures, and cost-effectiveness. Follow-up assessments will be conducted at 7 and 30 days postoperatively. DISCUSSION: This is the first randomized controlled trial designed to compare RC with LC in the treatment of benign gallbladder disease. The trial aims to evaluate the safety and non-inferiority of RC relative to LC, providing important evidence to guide the progress and adoption of robotic surgery in clinical practice. TRIAL REGISTRATION: This trial was registered on 14 July 2025 at ClinicalTrials.gov with the identifier NCT07119203, https://clinicaltrials.gov/study/NCT07119203 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Straatman J, Kooij CD, Mercer SJ, et al. Surgical Techniques: Robotic versus conventional Laparoscopic cholecystectomy IN benign Gallbladder disease: a randomized controlled, open, parallel, non-inferiority, single-center trial (STaRLING trial). Trials. 2026. PMID: 41731509. doi:10.1186/s13063-026-09458-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。